3/28/2016. Why you should care? Dana W. Dunne, MD, FACP Associate Professor of Medicine Yale University School of Medicine New Haven, Connecticut
|
|
- Osborn Thomas
- 6 years ago
- Views:
Transcription
1 Sexually Transmitted Diseases (STDs) and HIV: Top Ten Highlights for Clinicians Dana W. Dunne, MD, FACP Associate Professor of Medicine Yale University School of Medicine New Haven, Connecticut FINAL: New York, New York: March 23, 2016 Financial Relationships With Commercial Entities Dr Dunne has no relevant financial affiliations to disclose. (Updated 03/15/16) This presentation will include discussion of pharmaceuticals or devices that have not been approved by the FDA. Off-label use of extra-genital (rectal and pharyngeal) nucleic acid amplification tests (NAATs) for gonorrhea and chlamydia Thank you to Katherine Hsu, MD (Ratelle STD PTC) and others in NNPTC for slide sharing Slide 1 of 35 Why you should care? 1. HIV incidence rates remain high 2. STI- marker of high risk activity 3. STI- personal and public health concern 4. STI- enhance transmission of HIV Getting to zero = more effective STI screening and treatment in our HIV-infected patients Slide 2 of 35 1
2 Learning Objectives After attending this presentation, participants will be able to: Identify elements and rationale of an effective STI screening approach Recognize current STI epidemiology in HIV clinic and PrEP setting Describe recommended treatment and partner notification approaches for key bacterial STIs Outline- Slide 3 of 35 Let s take a trip to the clinic You are seeing Mr. G.P. for a routine HIV clinic appointment. He has well controlled HIV; self-describes as bisexual currently with a stable female partner. You have clinical questions about the following: 1. Are STI rates really that high in HIV clinic to warrant testing after initial intake? 2. Can you limit STI screening to only sites exposed? 3. Can t you pick up most things just by having him pee in a cup? Slide 4 of 35 STI rates are high in HIV clinics High baseline and incident STIs in HIV clinic US: HIV Primary Care clinic- 4 cities (n=557) 13% prevalent STI, 7% incident STI MSM- accounted for 94 % of infections (if trich excluded); 20% of incident STIs at 6 months most common: rectal CT, pharyngeal GC Risk factors polysubstance abuse ; >4 partners in 6 months Screening rates suboptimal 39% of HIV patients screened for GC/CT (vs 76% lipid screening) 10% Extragenital screening in MSM Mayer K, et al. STD 2012 Berry JAIDS, 2015 Slide 5 of 35 2
3 Women who do not need a pelvic exam as part of their clinic evaluation may be screened for chlamydia and gonorrhea by providing a self-collected vaginal swab. Your healthcare provider should give you instructions and make sure you understand what to do before you start. This page explains the procedure. (Illustrations courtesy of Gen-P robe Incorporated, San Diego CA) NC Sexually Transmitted Diseases Public Health Public Health Program Manual /Laboratory Testing & Standing Orders Self-Collected Swabs April 2011 Page 1 of 1 To collect a vaginal swab for gonorrhea/chlamydia testing: 1. Thoroughly wash your hands before starting. Undress from the waist down. 2. Read the instructions for using the test kit. 3. Open the kit package and set the tube of liquid to the side (do not open tube). 4. Partially peel open the swab package as directed, exposing the stick end of the swab (see picture 1). IMPORTANT: Do not touch the soft tip of the swab or lay the swab down. If the soft tip is touched, the swab is laid down, or the swab is dropped, ask for a new test kit. 5. Remove the swab from the package carefully; do not lay it down. 6. Hold the swab in the middle of the stick (shaft) with your thumb and forefinger (see picture 2). 7. Carefully insert the soft tip end of the swab into your vagina about 2 inches (5 cm) past the opening of the vagina (see picture 3). Gently rotate the swab for 10 to 30 seconds, making sure the swab touches the walls of the vagina so that moisture is absorbed by the swab. 8. Withdraw the swab without touching your skin. 9. While still holding the swab, carefully unscrew the cap from the tube of liquid. Do not spill the contents of the tube. (See picture 4.) 10. Immediately place the swab into the tube so that the soft tip of the swab is visible below the tube label. (See picture 5.) 11. Carefully break the swab shaft at the scoreline (dented line around middle of stick), being careful not to spill the liquid in the tube (picture 6). Leave the soft end of the swab in the tube and throw away the top portion of the swab shaft (picture 7). Tightly screw the cap onto the tube (picture 8). 12. If the contents of the tube are spilled or the tip of the swab touches anything, ask for a new test kit. 13. Return the tube as instructed by the nurse or doctor. 3/28/2016 Tip #1- Remember routine STI Testing during HIV care Initial care visit Syphilis serology Gonorrhea, chlamydia NAAT (at sites exposed) Women- Trichomonas testing (NAAT, culture) Cervical pap test per existing guidance (HIV OI guidelines) Hepatitis A/B/C testing ##More frequent screening dependent on risk! New sex partner, partner with concurrent partners or more than one partner, or partner with an STI High risk behavior Partner services, prevention counseling CDC 2015 Treatment Guidelines, HIVMA 2014 Slide 6 of 35 Tip # 2: Don t rely on symptoms or self-reported exposure Selective or symptom screening can miss up to half of STIs- (Van Liere 2013) Screening only urine misses majority of STIs in MSM- (Marcus 2011) Proportions of chlamydial and gonococcal infections among asymptomatic men who have sex with men that would be missed by different screening practices San Francisco City Clinic, Slide 7 of 35 Screening- What swab do I use? Genital Testing Men- Urine = urethral swab Women and Chlamydia Urine << Vaginal Swab; cervical Vaginal- provider or patient collected Self-Collected Vaginal Swabs for Gonorrhea Extragenital Testing* *check for lab validation locally Pharyngeal- Like strep throat swab Rectal- Provider or patient collected Slide 8 of 35 3
4 Tip #1 and 2- Universal screening every 3-6 months for atrisk patients Regardless of symptoms Regardless of site exposed Pharyngeal GC NAAT** Urine GC/CT NAAT Rectal GC/CT NAAT** Can be pt collected *In HIV-coinfected individuals, screen hep C at least annually **Off-label use - not FDA-approved for testing at extragenital sites, but many reference labs have validated the assay for use Slide 9 of 35 Your patient s STI screen results return. He has pharyngeal gonorrhea but chlamydia testing from all sites (using NAATs) is negative. How to treat? 1. Ceftriaxone 125 mg IM x 1 2. Ciprofloxacin 500 mg po x 1 plus azithromycin 1 gm po x 1 3. Cefixime 400 mg po x 1 4. Ceftriaxone 250 mg IM x 1 5. Ceftriaxone 250 mg IM plus azithromycin 1 gm po x 1 17% 4% 6% 0% Ceftriaxone 125 mg IM x 1 Ciprofloxacin 500 mg po x 1 plu... Cefixime 400 mg po x 1 Ceftriaxone 250 mg IM x 1 Ceftriaxone 250 mg IM plus az... 72% Slide 10 of 35 Tip #3- Use DUAL Treatment for Gonorrhea Gonorrhea- Uncomplicated Genital, Rectal, or Pharyngeal Infections Ceftriaxone 250 mg IM in a single dose* PLUS* Azithromycin 1 g orally * Regardless of CT test result Azithromycin 2 g orally removed as an alternative regimen *If CTX unavailable-cefixime 400 mg orally once (anorectal infection only) CDC 2015 STD Treatment Guidelines Slide 11 of 35 4
5 Tip #4-Rescreen 3-4 months after STI Women with CT, GC or trichomonas should be rescreened at 3 months after treatment. Men with CT or GC should be rescreened at 3 months after treatment. Patients diagnosed with syphilis should undergo follow up serology per current recommendations. Slide 12 of 35 You remember something about partner notification Expedited Partner Therapy (EPT) is legal in my state: 1. Yes 2. No 3. I don t know 64% 32% 4% Yes No I don t know Slide 13 of 35 Tip #5-EPT is effective and now legal in (most) all states Legal Status of EPT as of 2016 PDPT can prevent reinfection of index case and has been associated with a higher likelihood of partner notification Slide 14 of 35 5
6 EPT local details STATE Contact to CT Contact to GC Notes NY Azithromycin 1 gm Not sanctioned heterosexual NJ Azithromycin 1 gm CT Azithromycin 1 gm Cefixime 400 mg +AZ Cefixime 400 mg +AZ heterosexual ( MSM w caution ) heterosexual Slide 15 of 35 Your patient tells his female partner about EPT but she prefers to come to the clinic. She is known to be HIV+. You commence routine STI screening and treat her as a contact to GC. Her Trichomonas antigen test returns positive. Which of the following is recommended for treatment? 1. Metronidazole gel 2% intravaginally q hs 5 nights 2. Metronidazole 2 gm orally x 1 dose 3. Metronidazole 500 mg orally BID x 7 days 4. No treatment necessary as she is asymptomatic and not pregnant Metronidazole gel 2% intravagi... 8% Metronidazole 2 gm orally x % 45% Metronidazole 500 mg orally B.. 1% No treatment necessary as she.. Slide 16 of 35 Trichomonas treatment HIV+ women Recommended Regimen for Women with HIV Infection Metronidazole 500 mg orally twice daily x 7 days Rescreen in 3 months (ideally with NAAT) Slide 17 of 35 6
7 Tip #6- Employ Newer Testing Options for Trich Microscopy is inferior to new options, including Rapid antigen testing (OSOM) Nucleic acid amplification testing APTIMA TMA Trichomonas vaginalis assay May use same specimen types as used with gc/chl NAATs (i.e. vaginal swab, endocervical swab, urine) Huppert CID 2007 Test Sens Spec APTIMA TMA 98% 98% OSOM 90% 100% Culture 83% 100% Wet prep 56% 100% Slide adapted from Marrazzo, IDSA 2011 Slide 18 of 35 Mr G.P. lets one of his male partners know about the STD contact. Mr. O.S. comes to your clinic for GC screening and treatment. What else can you offer? 1. GC pharyngeal NAAT; GC/CT urine and rectal NAAT 2. Syphilis serology 3. Hepatitis B/C 4. HIV testing 5. Vaccination (Hep A/B, HPV) 6. PrEP GC pharyngeal NAAT; GC/CT ur... Syphilis serology 100% 0% 0% 0% 0% 0% Hepatitis B/C HIV testing Vaccination (Hep A/B, HPV) PrEP Slide 19 of 35 High burden of bacterial STIs /PrEP settings STUDY Baseline STI % Incident STI% PROUD 63% 51-57% IPERGAY 25-31% 20% Partners PrEP 10-15% McCormack Lancet 2016 Molina NEJM 2015 Baeten NEJM 2012 Slide 20 of 35 7
8 Tip #7- Screen for bacterial STI in PrEP clinic! Slide 21 of 35 Rethink CDC PrEP STI q 6 month screening guidelines? 21% incident STI in 6 months prior to PrEP start Relying on symptoms would miss -77% of STI at 3 months -68% of STI at 9 months Repeat patients responsible for bulk of incident infections Golub, S, et al, Abstract #869 CROI, 2016 Slide 22 of 35 Case continues Mr. O.S. has full STI screen and baseline HIV test, gets GC exposure treatment and starts daily tenofovir/emtricitabine. 3 months later he returns for an evaluation and STI screen is repeated. He reports he can barely read the instructions in the bathroom about selfobtaining rectal swab due to a recent blurriness in his L eye. 2 days later his Syphilis EIA returns POSITIVE with reflex RPR of 1:256. He admits to a suspicious rash two weeks ago which has now resolved. His rectal CT NAAT is positive. Management?? Slide 23 of 35 8
9 Rates of infectious syphilis rising in MSM especially HIV % HIV coinfected Prevalence (2011) 2.6% in HIV-negative MSM 10.1% in HIV-positive MSM 75% of all P & S syphilis in MSM Core group of HIV+ MSM disproportionately contribute Slide 24 of 35 Tip #8- Neurologic complaints should prompt consideration of neurosyphilis Symptoms Visual changes, hearing loss, facial weakness, stuttering stroke symptoms Entities- Symptomatic early neurosyphilis (SENS) Ocular- uveitis, chorioretinitis most common Otic- tinnitus, SNHL Cranial Nerve involvement Aseptic meningitis Meningovascular Slide 25 of 35 Syphilis- When to do an LP? 1. Signs or symptoms of neurosyphilis 2. Diagnosis of Tertiary syphilis 3. May benefit? -Not serologically responding to treatment (eg-4-fold drop 6-12 months in early syphilis) Interpretation: Si/sx and Pos CSF-VDRL= diagnostic of neurosyphilis Si/sx with abn CSF (prot >40, WBC >5) with NEG CSF- VDRL = consider neurosyphilis. Negative CSF-TPPA virtually excludes neurosyphilis CDC STD Tx Guidelines 2015 Slide 26 of 35 9
10 Case continued- Mr OS has LP, posterior uveitis confirmed by ophthalmologic exam, high dose IV penicillin started for ocular syphilis/neurosyphilis. Key points- Serologic follow 3,6,9,12,24 months Counsel about Jarisch-Herxheimer reaction Report to local Health Department within 24 hours of diagnosis (CDC Advisory Feb 8, 2016) Pre-antibiotic samples (whole blood, primary lesions, CSF or ocular fluid) saved and stored at -80 immediately on collection (for assistance contact Dr Allan Pillay at or ajp7@cdc.gov) Slide 27 of 35 Tip #9- Treatment regimen for rectal CT depends upon symptoms Scenario A: Rectal CT NAAT positive- asymptomatic pt Treat for uncomplicated CT Azithromycin 1 gm po x 1 or Doxycycline 100 mg po bid x 7 days* Scenario B: Rectal CT NAAT positive- symptoms of proctitis Treat for presumed LGV strain Doxycycline 100 mg po bid x 21 days Further testing to confirm?- LGV strain PCR not commercially available. NYC diagnostic LGV conundrums contact Dr Julie Schillinger (jschilli@health.nyc.gov) *may be superior in rectal CT infections?? RCT needed Slide 28 of 35 Tip #10! Want to know more about STDs? There s an app for that. CDC STD Treatment Guidelines App for Apple and Android Available now, FREE! (accept no competitors) Search STD Treatment in App store Download now! Slide 29 of 35 10
11 National- STD Clinical Consultation Network (STDCCN) NEW!!!!! Provides STD clinical consultation services within 1-5 business days, depending on urgency, to healthcare providers nationally Your consultation request is linked to your regional PTC s STD faculty Just a click away! Slide 30 of 35 Top Ten Tips to Take To Work 1. Remember to screen patients for STIs in your HIV clinic 2. Screen MSM and at risk heterosexuals in all sites, frequently 3. Employ dual treatment for Gonorrhea 4. Rescreen for bacterial STI in 3-4 months THANK YOU! 5. EPT is effective and legal in your state 6. Trichomonas diagnostics have improved- access them 7. PrEP setting STI rate high- screen often 8. Syphilis rates remain high; ask about neurologic symptoms 9. Symptoms drive treatment regimen of rectal CT infection in MSM 10. Fast resources available- Download the App Slide 31 of 35 EPT information National- New York - lth-topics/expedited-partner-therapy.page New Jerseyhttp:// /ept_facts.pdf Connecticuthttp:// _diseases/std/ept_clinical_advisory.pdf Slide 32 of 35 11
12 EPT- Practical Considerations in NYS Write EPT in body of script Can leave patient name, DOB, address blank and pharmacists can fill it DO NOT use for partners of patients w GC, syphilis Provider must 1. provide index patient w/ written materials 2. Counsel index patient to tell partner to read material 3. More info on website Fully electronic prescribing- end of March- stay tuned for EPT exception Slide 33 of 35 Back-Pocket GC Treatment Regimens: Alternatives for cephalosporin-allergic patients Trial conducted in Baltimore, Birmingham, Pittsburgh, San Francisco 401 men and women yrs 202 received gent 240 mg IM + azithro 2 g PO: 100% effective 199 received gemiflox 320 mg PO + azithro2 g PO: 99.5% effective Bottom line Probably fine for urogenital gonorrhea, but trial not powered for extra genital gonorrhea (though it worked in the few cases enrolled) Efficacy limited by tolerance: 8% vomited in the gemiflox + azithro group and needed re-treatment with standard cftx + azithro Kirkcaldy RD et al. CID 2014 Slide 34 of 35 12
Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.
Disclosures Management of STIs: Challenges in Practice I have no disclosures or conflicts of interest to report. Alison O. Marshall, MSN, FNP-C Associate Professor of Practice & Director of the Family
More informationUpdate on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH
Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH Division of Infectious Diseases University of Alabama at Birmingham School of Medicine Birmingham, Alabama Outline Syphilis in all its
More informationSTD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH
STD Essentials for the Busy Clinician Stephanie E. Cohen, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Medical Director, City Clinic San Francisco Department of Public Health Disclosures
More informationClinical Practice Objectives
STD Essentials for the Busy Clinician Susan S. Philip, MD, MPH Assistant Professor, Division of Infectious Diseases, UCSF Director, STD Prevention and Control Services San Francisco Department of Public
More informationNothing to disclose.
Update on Diagnosis and Treatment Lisa Winston, MD University of California, San Francisco/ Zuckerberg San Francisco General Nothing to disclose. 1 This talk will be a little depressing Rising incidence
More informationAnswers to those burning questions -
Answers to those burning questions - Ann Avery MD Infectious Diseases Physician-MetroHealth Medical Center Assistant Professor- Case Western Reserve University SOM Medical Director -Cleveland Department
More informationOverview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond?
Sexually Transmitted Diseases: What s New in the Guidelines and Beyond? Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public
More informationRETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance
RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance Ina Park, MD, MS University of California San Francisco California Prevention Training Center DISCLOSURE No Relevant
More informationExtragenital Gonorrhea and Chlamydia among MSM
Extragenital Gonorrhea and Chlamydia among MSM Laura Quilter, MD Infectious Disease and STD PTC Fellow University of Washington Division of Allergy and Infectious Diseases 3/28/2016 uwptc@uw.edu uwptc.org
More informationSexually Transmitted Diseases
Sexually Transmitted Diseases Ina Park, MD, MS California Prevention Training Center University of California San Francisco Dept of Family and Community Medicine Disclosures/Disclaimers No disclosures
More informationDisclosure Information Julie Stoltey, MD MPH
Courtesy CDC Public Health Image Library The New Yorker 2012 2016 Update on Testing, Treatment, and Gonorrhea Resistance Julie Stoltey, MD, MPH STD Control Branch-California Dept. of Public Health Assistant
More informationKhalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014
Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine April 2, 2014 E-mail your questions for the presenter to: maphtc@jhsph.edu DISCLOSURES OFF- LABEL USES
More informationSTI 2016: Where We Need to Go
STI 2016: Where We Need to Go Gail Bolan, M.D. Director, Division of STD Prevention National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and Prevention Sexually
More information5/1/2017. Sexually Transmitted Diseases Burning Questions
Sexually Transmitted Diseases Burning Questions Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Los Angeles, California FORMATTED: 04-03-17 Financial
More informationCLINICAL MANAGEMENT OF STDS
CLINICAL MANAGEMENT OF STDS Diana Torres-Burgos MD, MPH NYC STD/HIV Prevention Training Center STD/HIV Update Conference Grand Rapids, MI 3/11/2014 Outline Essential components of STD care management Sexual
More informationClinical Education Initiative TITLE: UPDATE ON MSM SEXUAL HEALTH. Speaker: Maureen Scahill, MS NP
Clinical Education Initiative Support@ceitraining.org TITLE: UPDATE ON MSM SEXUAL HEALTH Speaker: Maureen Scahill, MS NP 1/25/2017 2/10/2017 Update on MSM Sexual Health [video transcript] 00:00:08 - [Maureen]
More information6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?
BACTERIAL STDs IN A POST- HIV WORLD Tracey Graney, PhD, MT(ASCP) Monroe Community College Learning Objectives Describe the epidemiology and incidence of bacterial STDs in the U.S. Describe current detection
More informationNew Guidelines for Detection and Treatment of Sexually Transmitted Infections
UCSF Controversies in Women s health December 8, 2016 San Francisco, CA New Guidelines for Detection and Treatment of Sexually Transmitted Infections Disclosure I am a litigation consultant to a law firm
More information2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE
2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE Gale R. Burstein, MD, MPH, FAAP, FSAHM Commissioner, Erie County Department of Health, Clinical Professor of Pediatrics, SUNY at Buffalo School
More informationLearning Objectives. STI Update. Case 1 6/1/2016
Learning Objectives STI Update June 16 th, 2016 Madhu Choudhary, MD. FIDSA Assoc. Prof of Medicine Albany Medical College Review screening recommendations for STI in different patient populations Describe
More informationDisclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None
Disclosures None What s New in the 2015 CDC STD Treatment Guidelines Ina Park, MD, MS California STD/HIV Prevention Training Center UCSF Dept of Family and Community Medicine STD Control Branch California
More informationSTDs in HIV Clinical Care: New Guidelines on Treatment and Prevention
STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention Palliative Care Conference Faculty Development Conference August 13, 2015 Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS
More informationS403- Update on STIs for the Generalists
S403- Update on STIs for the Generalists Mobeen H. Rathore, MD Professor and Director University of Florida Center for HIV/AIDS Research Education and Service (UF CARES) Chief, Pediatric Infectious Diseases
More informationSyphilis in the 21 st Century: Sex, Sores, Science, and Surveillance. Syphilis in Men
Syphilis in the 21 st Century: Sex, Sores, Science, and Surveillance Syphilis in Men Kenneth A. Katz, MD, MSc, MSCE Kaiser Permanente, San Francisco, CA AAD Annual Meeting Washington, D.C. March 2, 2019
More informationClinical Guidelines Update (aka Know Your NAATs)
Clinical Guidelines Update (aka Know Your NAATs) WARNING: contains adult themes, sexual references and pictures that may be disturbing! Dr Heather Young Christchurch Sexual Health Centre heather.young@cdhb.health.nz
More informationTrends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017
Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017 1 Speaker Disclosure Dr. Woo has disclosed that she has no
More informationTO DECREASE THE CHANCE OF GETTING
POST ASSAULT MEDICATIONS Terri Stewart RN Naomi Sugar MD TO DECREASE THE CHANCE OF GETTING Pregnant STDs Chlamydia Gonorrhea Trichomonas Hep B HIV EMERGENCY CONTRACEPTION Plan B Levonorgestrel PLAN B Plan
More informationWhat's the problem? - click where appropriate.
STI Tool v 1.9 @ 16/11/2017 What's the problem? - click where appropriate. Male problems: screening urethral symptoms proctitis in gay men lumps or swellings ulcers or sores skin rash and/or itch Female
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationStephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os
STD Diagnosis and Treatment Ina Park, MD, MS STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Stephanie 23 year-old female presents for contraception,
More informationServices for GLBTQ Youth
Sexual Health Care Services for GLBTQ Youth Gale R Burstein, MD, MPH, FAAP, FSAHM Erie County Commissioner of Health Buffalo, NY Agenda Introduction Epidemiology Sexual health care services for YMSM Sexual
More informationClinical Cases from the STD Clinical Consultation Network
Clinical Cases from the STD Clinical Consultation Network Christine Johnston STD TCG April 24, 2017 Last Updated: uwptc@uw.edu uwptc.org 206-685-9850 STD Clinical Consultation Network (STDCCN) Developed
More informationSexually transmitted infections (in women)
Sexually transmitted infections (in women) Timothy Kremer, MD Assistant Professor, Department of Obstetrics and Gynecology University of North Texas Health Science Center Last official CDC guidelines:
More informationManagement of Syphilis in Patients with HIV
Management of Syphilis in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the Guideline Increase the numbers of NYS
More informationEmerging Issues in STDs and Resistance
Emerging Issues in STDs and Resistance Toye H. Brewer, MD Asst. Professor of Clinical Medicine University of Miami School of Medicine Co-Director- Fogarty International Training Program Outline Syphilis-
More informationChapter 11. Sexually Transmitted Diseases
Chapter 11. Sexually Transmitted Diseases General Guidelines Persons identified as having one sexually transmitted disease (STD) are at risk for others and should be screened as appropriate. Partners of
More informationSTDs and Hepatitis C
STDs and Hepatitis C Catherine S. O Neal, MD Assistant Professor of Clinical Medicine, Infectious Diseases Louisiana State University Health Sciences Center March 3, 2018 Objectives Review patient risk
More informationThe (likely) New 2010 CDC STD Treatment Guidelines Guideline Development Process. Overview
The (likely) New 2010 CDC STD Treatment Guidelines http://www.cdc.gov/std/treatment Deborah Cohan, MD, MPH University of California, San Francisco San Francisco General Hospital cohand@obgyn.ucsf.edu I
More informationGenital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham
Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management William M. Geisler M.D., M.P.H. University of Alabama at Birmingham Chlamydia and Gonorrhea Current Epidemiology Chlamydia Epidemiology
More informationSTI Indicators by STI
STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients
More informationDr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014
THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Dr Selena Singh Guy s and St Thomas NHS Foundation Trust, London 1-4 April 2014, Arena and Convention Centre Liverpool Performance of ceftriaxone 500mgcontaining
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationMSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs
Outline MSM = (at least) 9 patients /day Management in MSM&TGpopulations OPASSPUTCHAROEN M.D. CHULALONGKORNUNIVERSITY BANGKOK, TH /HIV Recreational drugs ual fluidity and HIV Risk behavior AIDS Patient
More informationDidactic Series. STD Screening & Management: Syphilis. Christian B. Ramers, MD, MPH
Didactic Series STD Screening & Management: Syphilis Christian B. Ramers, MD, MPH Assistant Medical Director Family Health Centers of San Diego Ciaccio Memorial Clinic 3/26/15 ACCREDITATION STATEMENT:
More informationNovos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]
Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections] Khalil Ghanem, MD, PhD Associate Professor of Medicine Directors, STD/HIV/TB
More informationSTIs: Practical Aspects of Management
STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS
More informationOverview. Disclosures. Sexually Transmitted Diseases: Key Clinical Information for 2017
Sexually Transmitted Diseases: Key Clinical Information for 2017 Susan S. Philip, MD, MPH Director, Disease Prevention and Control Branch Population Health Division San Francisco Department of Public Health
More informationExtragenital Chlamydia and Gonorrhea. Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance
Extragenital Chlamydia and Gonorrhea Angel Stachnik, MPH Sr. Epidemiologist Office of Epidemiology and Disease Surveillance Rate of Chlamydia (CT) and Gonorrhea (GC), Clark County, 2012-2016 600 Rate per
More informationGAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016
GAY MEN/MSM AND STD S IN NJ: TAKE BETTER CARE OF YOUR PATIENTS! STEVEN DUNAGAN SPECIAL PROJECTS COORDINATOR NJ DOH STD PROGRAM SEPTEMBER 27, 2016 TOPICS FOR DISCUSSION What medical providers should know
More informationOne week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection
One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection A Elgalib, A Skingsley, O Dosekun, S Alexander, CYW Tong, JA White. Ali Elgalib Consultant in GUM/HIV
More informationSexually Transmitted Disease Treatment Tables
Sexually Transmitted Disease Treatment Tables Federal Bureau of Prisons Clinical Practice Guidelines June 2011 Clinical guidelines are made available to the public for informational purposes only. The
More informationSexually Transmitted Diseases. Summary of CDC Treatment Guidelines
DC 2015 Sexually Transmitted Diseases Summary of CDC Treatment Guidelines These summary guidelines reflect the June 2015 update to the 2010 CDC Guidelines for Treatment of Sexually Transmitted Diseases.
More informationSYPHILIS (REPORTABLE)
SYPHILIS (REPORTABLE) PREAMBLE In BC, the diagnosis of syphilis is determined by the BCCDC Provincial STI/HIV Clinic physician directly or in coordination with the*physician or nurse practitioner (NP)
More informationGuidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing
Guidelines for the Laboratory Detection of Chlamydia trachomatis, Neisseria gonorrhoeae and Treponema pallidum Testing Recommendations from the an expert consultation meeting held at CDC January 13-15,
More informationComplex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes ReachMD Page 1 of 5
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationUpdate on Sexually Transmitted Infections among Persons Living with HIV
Update on Sexually Transmitted Infections among Persons Living with HIV Stephen A. Berry, MD PhD Assistant Professor of Medicine Johns Hopkins University Division of Infectious Diseases Abbreviations and
More informationWHAT DO U KNOW ABOUT STIS?
WHAT DO U KNOW ABOUT STIS? Rattiya Techakajornkeart MD. Bangrak STIs Cluster, Bureau of AIDS, TB and STIs, Department of Disease Control, MOPH, Thailand SEXUALLY TRANSMITTED INFECTIONS? STIs Infections
More informationMedical Director, Community & Behavioral Health Clinics Department of Health and Human Services
Patrick F. Luedtke MD, MPH Senior Public Health Officer Medical Director, Community & Behavioral Health Clinics Department of Health and Human Services I have no relevant financial disclosures Review current
More informationBest Practices in STD Partner Management
Best Practices in STD Partner Management An Overview of Patient-Delivered Partner Therapy (PDPT) and Counseling for Partner Notification and Treatment Amber Eisenmann, MS Director of Learning Exchange
More informationSex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046) Kenneth A. Katz, MD, MSc, MSCE Dermatologist, Kaiser Permanente, San Francisco, CA AAD Annual Meeting, Orlando, FL March 4, 2017
More informationSTIs. Sexually Transmitted Infections. Kimberly A. Workowski, MD, FACP, FIDSA Professor of Medicine Emory University Atlanta, Georgia
Sexually Transmitted Infections Kimberly A. Workowski, MD, FACP, FIDSA Professor of Medicine Emory University Atlanta, Georgia FORMATTED: 11/17/15 Learning Objectives After attending this presentation,
More informationWelcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts.
Welcome to: Coding Scenarios for STD Clinic Visits We will begin in a few minutes. There will be no sound until the webinar starts. Welcome to: Coding Scenarios for STD Clinic Visits You are using audio
More informationX-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers
X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in
More informationClinical Education Initiative SEXUALLY TRANSMITTED INFECTIONS. Speaker: Kimberly Workowski, MD, FACP, FIDSA
Clinical Education Initiative Support@ceitraining.org SEXUALLY TRANSMITTED INFECTIONS Speaker: Kimberly Workowski, MD, FACP, FIDSA 2/8/2017 Sexually Transmitted Infections [video transcript] 00:00:03 What
More informationSexually Transmitted Diseases:
Sexually Transmitted Diseases: Diagnosis and Management Department of Internal Medicine, Division of Infectious Diseases University of New Mexico A 21 year old woman comes to your clinic asking to be checked
More informationSexual Health in Adolescents Progress in Prevention of STIs: Beyond the Latex Barrier
Sexual Health in Adolescents Progress in Prevention of STIs: Beyond the Latex Barrier Katherine Hsu, MD, MPH* Medical Director, Division of STD Prevention Director, Ratelle STD/HIV Prevention Training
More informationCHLAMYDIA/GC AMPLIFIED RNA ASSAY
Lab Dept: Test Name: Microbiology/Virology CHLAMYDIA/GC AMPLIFIED RNA ASSAY General Information Lab Order Codes: CGRNA Synonyms: CPT Codes: Test Includes: Chlamydia trachomatis/neisseria gonorrhoeae by
More informationAddressing STIs among MSM: A Clinical and Public Health Update
Addressing STIs among MSM: A Clinical and Public Health Update Kevin L. Ard, MD, MPH National LGBT Health Education Center, Fenway Institute Infectious Disease Division, Massachusetts General Hospital
More informationLooking at NY: Our rate of chlamydia is higher than the US as a whole; we rank 13th among all states.
1 In this presentation, we will discuss: What are the most common STDs in NYS What are the most common STDs Can I get gonorrhea from oral sex How do you know if you/or your partner has an STD? Does getting
More informationLymphogranuloma Venereum (LGV) Surveillance Project
Lymphogranuloma Venereum (LGV) Surveillance Project Lymphogranuloma venereum (LGV) is a systemic, sexually transmitted disease (STD) caused by a type of Chlamydia trachomatis (serovars L1, L2, L3) that
More informationGuidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:
Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes
More informationUpdated Guidelines for Post-Assault Testing and Treatment
Updated Guidelines for Post-Assault Testing and Treatment Ann S. Botash, MD Professor of Pediatrics October 5, 2016!" Disclosure Statement Ann S. Botash, MD, has no financial relationships with any commercial
More informationBest practices in chlamydia (CT) and gonorrhea (GC) screening in a changing healthcare environment:
Best practices in chlamydia (CT) and gonorrhea (GC) screening in a changing healthcare environment: Lessons from the Infertility Prevention Project (IPP) Goldenkranz Salomon S., Fine D., Curtiss J., Nakatsukasa-Ono
More informationSTI Diagnostics Redesign. HVS and Chlamydia Resource Pack
Important! 1. This information is intended to support practitioners in the management of common sexual health problems and it is therefore essential that each doctor and nurse receives a copy. 2. Future
More informationNew CT/GC Tests. CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009
CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009 Richard Steece, Ph.D., D(ABMM) DrRSteece@aol.com New CT/GC Tests New Nucleic Acid Amplification Tests (NAATs) for
More informationThe Great Imitator Revealed: Syphilis
The Great Imitator Revealed: Syphilis Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles David Geffen School of Medicine Los Angeles, California Learning
More information87491 Chlamydia trachomatis, amplified probe technique Neisseria gonorrhoeae, amplified probe technique. Virology (Performed on Mpls campus)
Lab Dept: Test Name: Microbiology/Virology CHLAMYDIA & GONORRHOEAE PCR General Information Lab Order Codes: CGPCR Synonyms: CPT Codes: Test Includes: Chlamydia trachomatis/neisseria gonorrhoeae by Nucleic
More informationWomen s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins
Women s Sexual Health: STI and HIV Screening Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins I have no disclosures! Review most recent rates of STIs and HIV across the
More information4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE
Laboratory Testing Update Specimen Transport Changes dated 12-24-14 SEH Laboratory is making significant changes to specimen transports! The Laboratory is introducing new testing platforms along with working
More informationPodcast Transcript. Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43
Podcast Transcript Title: The STD Crisis in America: Where We Are and What Can Be Done Speaker Name: Bradley Stoner, MD, PhD Duration: 00:30:43 NCTCFP: Welcome to this podcast sponsored by the National
More informationClinical Education Initiative ADOLESCENTS AND STDS: CASE STUDIES. Tara Babu, MD
Clinical Education Initiative Support@ceitraining.org ADOLESCENTS AND STDS: CASE STUDIES Tara Babu, MD 2/16/2017 Adolescents and STDs: Case Studies [video transcript] 00:00:08 - Hello, my name is Tia Babu
More informationSexually Transmitted Diseases
Table of content Sexually Transmitted Diseases Judith A. Lightfoot DO, FACOI Update on the prevalence of STD s in the US Which populations are greatly affected? Should we be alarmed? How does this affect
More informationPREP CASES BREAKOUT CASE 1: COPING WITH PILL FATIGUE PE/LABS
PREP CASES BREAKOUT CASE 1: COPING WITH PILL FATIGUE 28 year-old HIV-negative MSM CC: Rectal Mass and Diarrhea x 2 weeks PMH: No chronic medical issues - Diagnosed with secondary syphilis 9 months ago
More informationGetting Prepped for PrEP. Ken Ho, MD, MPH World AIDS Day
Getting Prepped for PrEP Ken Ho, MD, MPH World AIDS Day Objectives HIV epidemiology What is PrEP? Does it Work? Who gets PrEP? How do I prescribe PrEP What to do at the first visit? What to do at follow
More informationSyphilis Treatment Protocol
STD, HIV, AND TB SECTION Syphilis Treatment Protocol CLINICAL GUIDANCE FOR PRIMARY AND SECONDARY SYPHILIS AND LATENT SYPHILIS www.lekarzol.com (4/2016) Page 1 of 8 Table of Contents Description... 3 Stages
More informationPART 3: HOW TO PROVIDE STI TEST RESULTS
PART 3: HOW TO PROVIDE STI TEST RESULTS HOW TO PROVIDE STI TEST RESULTS When an individual receives a positive result, providers are required by law to provide treatment or refer the patient to treatment
More information2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing
2012 California Clinical Laboratory Survey: STD/HIV/Hepatitis Testing Joan M. Chow, MPH, DrPH Surveillance, Epidemiology, Assessment & Evaluation Section Sexually Transmitted Disease Control Branch Division
More informationHIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO. Brent K. Sugimoto, MD, MPH Kaiser Permanente. 29th Annual East Bay HIV Update June 3, 2016
HIV & THE MEDICAL HOME A NEW FRONT FOR GETTING TO ZERO 29th Annual East Bay HIV Update June 3, 2016 Brent K. Sugimoto, MD, MPH Kaiser Permanente Photo Credit: C. GoldsmithContent Providers: CDC/ C. Goldsmith,
More information2/17/2017. Sexually Transmitted Diseases in Children: Is it Abuse? General Considerations. Judy Guinn, MD WI CAN Educational Series February 17, 2017
Sexually Transmitted Diseases in Children: Is it Abuse? Judy Guinn, MD WI CAN Educational Series February 17, 2017 Disclosure Information for: Judy Guinn, MD Sexually Transmitted Diseases in Children:
More information4/6/17 UNPRECEDENTED HIGH. Shelagh Larson, RNC, WHNP, NCMP
Shelagh Larson, RNC, WHNP, NCMP UNPRECEDENTED HIGH Total combined cases of chlamydia, gonorrhea, and syphilis reported in 2015 reached the highest number ever, according to the annualmore than 1.5 million
More informationSex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)
Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046) Kenneth A. Katz, MD, MSc, MSCE Dermatologist, Kaiser Permanente, San Francisco, CA AAD Annual Meeting, San Diego, CA February
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationLET S TALK about Sticking with your treatment plan
LET S TALK about Sticking with your treatment plan HOW ONGOING HIV CARE HELPS YOU LIVE A LONGER AND HEALTHIER LIFE Your treatment plan is vital to your overall health (and to reducing HIV transmission)
More informationEdward W. Hook, III, M.D.
Challenging Cases Edward W. Hook III M.D. Professor and Director Division of Infectious Diseases University of Alabama at Birmingham And PI, Alabama/North Carolina STD PTC Edward W. Hook, III, M.D. Grant/Research
More informationJulie Nelson RNC/WHNP-BC Epidemiology NURS 6313
Julie Nelson RNC/WHNP-BC Epidemiology NURS 6313 Chlamydia Most frequently reported bacterial STI in the US In 2006, In U.S. 1,030,911 cases were reported. Estimated 2,291,000 infections in 14-39 year olds.
More informationWhat s new in sexually-transmitted infections?
What s new in sexually-transmitted infections? Kevin L. Ard, MD, MPH National LGBT Health Education Center, Fenway Institute Infectious Disease Division, Massachusetts General Hospital Director, Genitourinary
More informationPre-exposure Prophylaxis and Primary Care
Pre-exposure Prophylaxis and Primary Care National Latino HIV and Hepatitis C Conference June 7 th, 2016 Allison Finkenbinder, MSN, WHNP-BC Denver Prevention Training Center Who s in the audience? Disclosures
More informationSexual health screening
Sexual health screening This guideline provides screening recommendations that are based on anatomy and is inclusive of genderaffirming surgeries and hormone therapy. All patients should be screened according
More informationINTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management
INTRAUTERINE DEVICES AND INFECTIONS Tips for Evaluation and Management Objectives At the end of this presentation, the participant should be able to: 1. Diagnose infection after IUD placement 2. Provide
More informationManagement of Gonorrhea in Adolescents and Adults in the United States
SUPPLEMENT ARTICLE Management of Gonorrhea in Adolescents and Adults in the United States Sarah Kidd 1 and Kimberly A. Workowski 1,2 1 Division of STD Prevention, Centers for Disease Control and Prevention,
More information